DeutschNewstral
Article
bizjournals.com on 2016-07-05 15:30
FDA accepts Cempra's application for next-gen pneumonia treatment
Related news
- MShares of Fate Therapeutics up 4.1% in premarket trade after FDA accepts IND application for potential cancer treatmentmarketwatch.com
FDA accepts Coherus’s resubmitted pegfilgrastim biosimilar applicationjdsupra.com- FDA rejects AstraZeneca's new drug application for blood disorder treatmentbizjournals.com
- FDA rejects J&J application for new rheumatoid arthritis treatmentbizjournals.com
- FDA Accepts Application From Samsung Bioepis and Biogen For Lucentis® (ranibizumab) Biosimilarjdsupra.com
- DFDA accepts new diabetes drug application from Boehringer Ingelheim and Eli Lillydailyvoiceplus.com
- MPalatin shares surge 9% premarket after FDA accepts for review treatment for HSDDmarketwatch.com
- MTrevena shares rally as FDA accepts painkiller marketing application for reviewmarketwatch.com
- MBiogen's stock rallies 11% after FDA accepts application for experimental Alzheimer's drugmarketwatch.com
- FDA Accepts Bio-Thera Solutions’ Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®jdsupra.com
- China’s FDA Accepts JHL Biotech’s Clinical Trial Application for Rituximab Biosimilar in NHLjdsupra.com
- Sarepta gains after-hours as FDA accepts application for Duchenne drug approvalbizjournals.com
- MUPDATE: Acorda Therapeutics shares crater 26% premarket after FDA rejects application for Parkinson's treatmentmarketwatch.com
- MClovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatmentmarketwatch.com
- Raleigh firm seeks FDA approval for next-gen treatment low testosteronebizjournals.com
- FDA Grants Priority Review to Merck’s Application for KEYTRUDA (pembrolizumab) as Part of Treatment for Early-Stage Cervical Cancerjdsupra.com
FDA Accepts Application for GTx Clinical Trialmemphisdailynews.com- FDA Accepts Application For GTx Clinical Trialmemphisdailynews.com
FDA approves Boehringer’s asthma treatmentwestfaironline.com- Cempra receives FDA committee support for pneumonia drugbizjournals.com